Latest imported 13F data
โณ
Showing Q3 2025 data
HedgeTrack has imported Q4 2025 data overall, but Krensavage Asset Management, LLC's latest available filing here is Q3 2025.

Krensavage Asset Management, LLC

โ€ขCIK: 1609251โ€ขFiling: Q3 2025

**Krensavage Asset Management, LLC** manages $235M across a concentrated portfolio of 17 positions. The fund exhibits significant conviction in select names, with UTH representing the largest single holding at $40.9M. Key allocations also include ENTA ($25.3M), MRX ($22.1M), and BMRN ($22.0M). This structure suggests a focused, high-conviction approach targeting specific market opportunities.

Total AUM
$234.7M
QoQ Performance
+24.2%
Positions
17
Top 10 Concentration
86.2%
Latest Filing
Q3 2025

Top Holdings Allocation

UTHR
ENTA
JAZZ
BMRN
EXEL
SUPN
SNY
AVAD
UTHR17.4%
ENTA10.8%
JAZZ9.4%
BMRN9.4%
EXEL9.1%
SUPN7.4%
SNY6.5%
AVADEL6.2%

๐Ÿ“ˆ Biggest Buys

BMRN
BIOMARIN PHARMACEUTICAL INC
NEW
9.4% of portfolio
SNY
SANOFI-ADR
+117.5%
6.5% of portfolio
BIIB
BIOGEN INC
NEW
0.6% of portfolio
EXEL
EXELIXIS INC
+5.1%
9.1% of portfolio
VNDA
VANDA PHARMACEUTICALS INC
+15.2%
2.5% of portfolio

๐Ÿ“‰ Biggest Sells

INDV
INDIVIOR PLC
-65.2%
3.5% of portfolio
CAH
CARDINAL HEALTH INC
-44.9%
4.9% of portfolio
SUPN
SUPERNUS PHARMACEUTICALS INC
-23.1%
7.4% of portfolio
UTHR
UNITED THERAPEUTICS CORP
-3.5%
17.4% of portfolio
โ€”
AVADEL PHARMACEUTICALS
-0.3%
6.2% of portfolio

Sector Breakdown

Other100.0%

๐Ÿšช Exited Positionssold since Q2 2025

JNJ
JOHNSON & JOHNSON
SOLD
$6.1M

Changes from Q2 2025

NEW3 new positions
โ†‘5 increased
โ†“5 decreased

Historical Filings

Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022